Y, Z., X, W., J, L., K, Z., Z, R., J, X., & Y, W. (2026). Novel Hsp90 inhibitor JD‑02 inhibits HSV‑1 infection via the Raf/MEK/ERK signaling pathway. International journal of molecular medicine, 57(6), . https://doi.org/10.3892/ijmm.2026.5810
Chicago Style (17th ed.) CitationY, Zhu, Wang X, Lin J, Zheng K, Ren Z, Xiao J, and Wang Y. "Novel Hsp90 Inhibitor JD‑02 Inhibits HSV‑1 Infection via the Raf/MEK/ERK Signaling Pathway." International Journal of Molecular Medicine 57, no. 6 (2026). https://doi.org/10.3892/ijmm.2026.5810.
MLA (9th ed.) CitationY, Zhu, et al. "Novel Hsp90 Inhibitor JD‑02 Inhibits HSV‑1 Infection via the Raf/MEK/ERK Signaling Pathway." International Journal of Molecular Medicine, vol. 57, no. 6, 2026, https://doi.org/10.3892/ijmm.2026.5810.